Connie Chang is the founder of ONL Therapeutics. ONL Therapeutics has raised $148M in total funding. Latest round: Series B. Based in Ann Arbor, Michigan.
Connie Chang is the Chief Operating Officer (COO) of ONL Therapeutics, a clinical-stage biopharmaceutical company focused on retinal disease therapies. She was appointed to this role in January 2021, and has been instrumental in advancing ONL1204 into Phase 2 clinical trials.
Full founder directory · Investor directory · Company funding database · Fundraising library